PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer

Serial liquid biopsies consistently showed AR alterations linked to poorer outcomes; Findings support “real-time” molecular testing to guide personalized care

2026-02-26
(Press-News.org) MIAMI, FLORIDA (EMBARGOED UNTIL FEB. 26, 2026, AT 10 A.M. EST) – A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that androgen receptor (AR) alterations consistently emerged and were linked to poorer outcomes across therapies. The findings, published Feb. 26 in Clinical Cancer Research, a journal of the American Association for Cancer Research, suggest that a single genomic test at diagnosis is no longer sufficient for managing advanced prostate cancer and support using real-time molecular testing to guide more personalized care in advanced prostate cancer.

Under the pressure of treatment, metastatic prostate cancer adapts—persistently rewiring itself to survive. For clinicians, the challenge has always been timing: knowing when—and how—the disease has changed before it outruns the next line of therapy. The new study led by Chinmay T. Jani, M.D., Chief Fellow, Hematology and Oncology, at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, suggests those answers may already be circulating in patients’ blood.

Using serial liquid biopsies, the research team tracked how fragments of tumor DNA—known as circulating tumor DNA, or ctDNA—shift over time in patients with metastatic castration‑resistant prostate cancer (mCRPC). Castration-resistant refers to prostate cancer that no longer responds to hormone therapy treatments.

The research was conducted as a multi-center collaboration, bringing together investigators from Sylvester, the University of California, San Diego (UC San Diego), Moores Cancer Center, the University of California, San Francisco, Scripps Research Institute and Guardant Health, Inc., reflecting the scale and translational reach of the work. The project was developed and initiated at UC San Diego and conducted under mentorship from Rana McKay, M.D., FASCO, associate director, clinical research and professor of medicine, urology, and radiation medicine and Applied Sciences at the Moores Cancer Center at UC San Diego.

“This work highlights the power of real-time molecular monitoring to inform precision medicine in advanced prostate cancer,” said McKay. “As we develop the next generation of therapies, including novel AR-targeted agents and rational combinations, understanding how tumors evolve under treatment pressure will be critical to delivering the right drug to the right patient at the right time.”

Traditionally, genomic testing in prostate cancer has relied on tumor tissue—often collected years earlier, sometimes from sites that no longer reflect the dominant disease. Liquid biopsy offers a different lens—capturing what the cancer is doing now.

In this real-world analysis, researchers examined paired ctDNA samples taken before treatment and again after treatment discontinuation, a window that often marks disease progression. The study included more than 1,700 patients, drawing from one of the largest linked clinical genomic databases available.

Across all treatment groups, tumors showed a clear pattern: mutation burden increased after therapy, underscoring the selective pressure exerted by modern prostate cancer treatments.

“Cancer adapts under stress,” Jani said. “What we’re seeing in ctDNA is evolution happening in real time.”

Among the many genetic shifts observed, one stood out consistently—the androgen receptor, a central driver of prostate cancer growth.

After treatment with androgen receptor pathway inhibitors (ARPIs), PARP inhibitors and even taxane chemotherapy, patients were significantly more likely to develop AR amplifications or AR mutations, particularly in regions that allow the receptor to remain active despite therapy. These alterations act like a master switch, keeping cancer growth signals turned on even when treatments are designed to shut them down.

Importantly, the presence of AR alterations was not just common—it was consequential. Across all treatment classes, patients with AR-altered tumors experienced shorter overall survival, faster treatment discontinuation and earlier need for subsequent therapy.

“AR alterations emerged as a consistent marker of more aggressive disease,” Jani said. “They mattered regardless of which therapy patients received.”

The study also revealed how resistance develops to newer targeted therapies. Among patients treated with PARP inhibitors, some tumors acquired BRCA reversion mutations, restoring DNA repair pathways and blunting the effectiveness of treatment. Others accumulated changes in genes such as TP53, EGFR and PIK3CA, hallmarks of genomic instability and treatment resistance.

Taken together, the findings suggest that a single genomic test at diagnosis is no longer sufficient for managing advanced prostate cancer. As tumors evolve, their vulnerabilities—and their escape routes—change.

“Serial ctDNA testing gives us a moving picture, not a snapshot,” Jani said. “That has real implications for precision oncology.”

By capturing tumor evolution as it unfolds, liquid biopsy may help clinicians make more informed, timely decisions—adjusting treatment strategies before resistance becomes clinically evident. The findings also support continued development of next-generation therapies, including androgen receptor degraders and novel combination approaches designed to overcome treatment resistance.

“This approach allows us to learn from the disease as it changes,” Jani said. “And ultimately, to tailor care more precisely for each patient.”

While observational, the study provides a strong biological rationale for integrating serial ctDNA testing into routine care for men with mCRPC. As precision oncology continues to advance, the ability to monitor tumor evolution through a simple blood draw may prove essential—not just for choosing the right treatment, but for choosing it at the right moment.

about Sylvester research on the InventUM blog and follow @SylvesterCancer on X for the latest news on its research and care.

# # #

END



ELSE PRESS RELEASES FROM THIS DATE:

FAU Harbor Branch awarded $900,000 for Gulf of America sea-level research

2026-02-26
The Gulf of America is experiencing accelerated sea-level rise due to a complex interplay of ocean dynamics, steric effects and vertical land motion. These changes pose serious challenges for coastal communities, particularly rural and under-resourced areas that lack the infrastructure and data to plan for flooding and long-term adaptation. Understanding the drivers of regional sea-level variability and developing actionable forecasting tools is critical for supporting decision-making and resilience planning. Florida Atlantic University’s Harbor Branch Oceanographic Institute has been awarded a $900,000, four-year ...

Terminal ileum intubation and biopsy in routine colonoscopy practice

2026-02-26
Background and objectives Terminal ileum intubation is considered the completion step of colonoscopy and is usually performed to assess the ileum. The histological examination of the ileal mucosa, which is acquired during terminal ileum intubation, may allow an accurate diagnosis. However, there is no absolute consensus on when ileoscopy and biopsy should be attempted. As a result, we aimed to evaluate whether terminal ileum intubation and biopsy should be performed routinely. Methods Systematic searches were performed in the PubMed, EMBASE, and Cochrane Library databases, as well as the Science Citation Index via the Web of Science ...

Researchers find important clue to healthy heartbeats

2026-02-26
PULLMAN, Wash. — A tiny region in a little-known muscle protein may hold the key to a healthy, steady heartbeat, as well as possible clues to future treatment of devastating heart ailments. Washington State University researchers have found a region of a protein called leiomodin that is critical in maintaining the length of tiny filaments that control a person’s heartbeat. The work, in collaboration with researchers from the University of Arizona and Mount Sinai School of Medicine in New York, is featured in the high-profile journal Circulation Research. “It’s a small part of a big protein ...

Characteristic genomic and clinicopathologic landscape of DNA polymerase epsilon mutant colorectal adenocarcinomas

2026-02-26
Background and objectives DNA polymerase epsilon catalytic subunit A (POLE) gene plays a crucial role in DNA repair and chromosomal replication. Mutations in the POLE gene have been linked to cancer, particularly colorectal carcinoma (CRC). However, the genomic landscape and pathological significance of POLE mutant CRC remain underreported. This study aimed to characterize the clinicopathologic features and genomic landscape of CRC harboring POLE mutations and to investigate the implications of co-occurring genetic alterations. Methods We ...

Start school later, sleep longer, learn better

2026-02-26
High school students often have trouble getting to bed at a reasonable time, which makes it difficult for them to start school early in the morning. This is because teenagers are biologically wired to fall asleep later than adults, with their biological clock shifting progressively later throughout adolescence. The result is that most teenagers don’t get enough sleep on school days, and their sleep deficits increase as the week progresses. “This is concerning, as chronic sleep deprivation not only affects well-being, but also has a measurable impact on mental health, physical ...

Many nations underestimate greenhouse emissions from wastewater systems, but the lapse is fixable

2026-02-26
Nations worldwide underestimate greenhouse gas emissions from wastewater facilities, but updating measurements could fix this. Nations worldwide underestimate greenhouse gas emissions from wastewater systems, research from Princeton University shows. Outdated inventory methods and failure to include items like latrines and untreated sewage in national reports are main reasons. In an article published Feb. 11 in the journal Nature Climate Change, the researchers report that nations underestimated emissions of gases including methane ...

The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds

2026-02-26
The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomised controlled trial published in The Lancet. Additionally, participants taking orforglipron had significantly greater reductions in body weight than those taking oral semaglutide.   Currently the only available oral ...

Pediatric investigation study highlights two-way association between teen fitness and confidence

2026-02-26
Physical fitness and psychological resilience develop side by side during adolescence, a life stage that lays the foundation for adult health. Cardiorespiratory endurance, muscular strength, and agility are well-known predictors of cardiometabolic health, while self-efficacy, defined as the belief in one’s ability to overcome challenges, shapes motivation, persistence, and coping strategies. Although both have independently been linked to healthier lifestyles and improved well-being, less attention has been given to how they may influence ...

Researchers develop cognitive tool kit enabling early Alzheimer's detection in Mandarin Chinese

2026-02-26
Asian Americans are the fastest-growing group of older adults in the U.S., but they often face language and cultural barriers when seeking care for dementia-related symptoms.  As part of a broader mission to tackle these challenges, a Rutgers Health-led study involving internationally renowned clinicians and scientists from the National Institute on Aging-funded Rutgers-NYU Resource Center for Alzheimer’s Disease and Research Center in Asian and Pacific Americans and Stanford Alzheimer’s Disease Research Center has proposed a ...

New book captures hidden toll of immigration enforcement on families

2026-02-26
“They took Dad.” That sentence opens Carolina Valdivia’s new book, Sanctuary Making: Immigrant Families Reshaping Geographies of Deportability, published this month by the University of California Press. The book chronicles what happens to families in the aftermath of those three words, and the extraordinary lengths that ordinary people go to in order to protect the ones they love. “This is a book with a sense of urgency” wrote Emmy Award–winning journalist and former Univision News anchor Jorge Ramos in his review. “From the first line — ...

LAST 30 PRESS RELEASES:

When safety starts with a text message

CSIC develops an antibody that protects immune system cells in vitro from a dangerous hospital-acquired bacterium

New study challenges assumptions behind Africa’s Green Revolution efforts and calls for farmer-centered development models

Immune cells link lactation to long-lasting health

Evolution: Ancient mosquitoes developed a taste for early hominins

Pickleball players’ reported use of protective eyewear

Changes in organ donation after circulatory death in the US

Fertility preservation in people with cancer

A universal 'instruction manual' helps immune cells protect our organs

Fifteen-year results from SWOG S0016 trial suggest follicular lymphoma is curable

The breasts of a breastfeeding mother may protect a newborn from the cold – researchers offer a new perspective on breast evolution

More organ donations now come from people who die after their heart stops beating

How stepping into nature affects the brain

Study: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer

FAU Harbor Branch awarded $900,000 for Gulf of America sea-level research

Terminal ileum intubation and biopsy in routine colonoscopy practice

Researchers find important clue to healthy heartbeats

Characteristic genomic and clinicopathologic landscape of DNA polymerase epsilon mutant colorectal adenocarcinomas

Start school later, sleep longer, learn better

Many nations underestimate greenhouse emissions from wastewater systems, but the lapse is fixable

The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds

Pediatric investigation study highlights two-way association between teen fitness and confidence

Researchers develop cognitive tool kit enabling early Alzheimer's detection in Mandarin Chinese

New book captures hidden toll of immigration enforcement on families

New record: Laser cuts bone deeper than before

Heart attack deaths rose between 2011 and 2022 among adults younger than age 55

Will melting glaciers slow climate change? A prevailing theory is on shaky ground

New treatment may dramatically improve survival for those with deadly brain cancer

Here we grow: chondrocytes’ behavior reveals novel targets for bone growth disorders

Leaping puddles create new rules for water physics

[Press-News.org] Study: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer
Serial liquid biopsies consistently showed AR alterations linked to poorer outcomes; Findings support “real-time” molecular testing to guide personalized care